Novel Pituitary Ligands: Peroxisome Proliferator Activating Receptor-γ

By Heaney Anthony P.  

Pituitary, Vol. 6, Iss. 3, 2003-01 ,pp. : 153-159

Springer Publishing Company

Access to resources Recommend Favorite

Peroxisome proliferator-activated receptor γ (PPAR-γ) agonist increases plasma adiponectin levels in type 2 diabetic patients with proteinuria

By Yilmaz Mahmut   Sonmez Alper   Caglar Kayser   Gok Deniz   Eyileten Tayfun   Yenicesu Müjdat   Acikel Cengizhan   Bingol Necati   Kilic Selim   Oguz Yusuf   Vural Abdulgaffar  

Endocrine Journal, Vol. 25, Iss. 3, 2004-12 ,pp. : 207-214

Humana Press, Inc

Access to resources Recommend Favorite

Effects of peroxisome proliferator-activated receptor (PPAR)-α and PPAR-γ agonists on glucose and lipid metabolism in patients with type 2 diabetes mellitus

By Bajaj M.   Suraamornkul S.   Hardies L.   Glass L.   Musi N.   DeFronzo R.  

Diabetologia, Vol. 50, Iss. 8, 2007-08 ,pp. : 1723-1731

Springer Publishing Company

Access to resources Recommend Favorite

Selective Peroxisome Proliferator-Activated Receptor-γ Modulation in the Treatment of Hypertension and Metabolic Syndrome: The Role of Angiotensin II Receptor Blockers

By Borghi Claudio  

High Blood Pressure & Cardiovascular Prevention, Vol. 13, Iss. 3, 2006-01 ,pp. : 81-84

Adis International

Access to resources Recommend Favorite

Selective Peroxisome Proliferator-Activated Receptor-γ Modulation to Reduce Cardiovascular Risk in Patients with Insulin Resistance

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 7, Iss. 1, 2012-04 ,pp. : 33-41

Bentham Science Publishers

Access to resources Recommend Favorite